Home blood pressure monitoring: Australian Expert Consensus Statement. 2015

James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
aMenzies Institute for Medical Research, University of Tasmania, Hobart bBaker IDI Heart and Diabetes Institute, Melbourne cMonash University, Clayton, Victoria dEndocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland eSchool of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth fCentre for Research in Evidence Based Practice, Bond University, Queensland, Australia.

Measurement of blood pressure (BP) by a doctor in the clinic has limitations that may result in an unrepresentative measure of underlying BP which can impact on the appropriate assessment and management of high BP. Home BP monitoring is the self-measurement of BP in the home setting (usually in the morning and evening) over a defined period (e.g. 7 days) under the direction of a healthcare provider. When it may not be feasible to measure 24-h ambulatory BP, home BP may be offered as a method to diagnose and manage patients with high BP. Home BP has good reproducibility, is well tolerated, is relatively inexpensive and is superior to clinic BP for prognosis of cardiovascular morbidity and mortality. Home BP can be used in combination with clinic BP to identify 'white coat' and 'masked' hypertension. An average home BP of at least 135/85 mmHg is an appropriate threshold for the diagnosis of hypertension. Home BP may also offer the advantage of empowering patients with their BP management, with benefits including increased adherence to therapy and lower achieved BP levels. It is recommended that, when feasible, home BP should be considered for routine use in the clinical management of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001315 Australia The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra. Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)
D012648 Self Care Caring for self when ill or positive actions and adopting behaviors to prevent illness. Self-Care,Care, Self
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D059466 White Coat Hypertension Phenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings. White Coat Syndrome,Isolated Clinic Hypertension,Clinic Hypertension, Isolated,Hypertension, Isolated Clinic,Hypertension, White Coat,Syndrome, White Coat
D059468 Masked Hypertension Phenomenon where increased BLOOD PRESSURE readings taken in non-clinical settings (e.g., HOME BLOOD PRESSURE MONITORING) do not replicate in clinical settings. Hypertension, Masked,Hypertensions, Masked,Masked Hypertensions
D018660 Blood Pressure Monitoring, Ambulatory Method in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy. Ambulatory Blood Pressure Monitoring,Monitoring, Ambulatory Blood Pressure,Blood Pressure Monitoring, Home,Blood Pressure Monitoring, Self,Home Blood Pressure Monitoring,Self Blood Pressure Monitoring

Related Publications

James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
April 2018, Journal of human hypertension,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
March 2009, Lancet (London, England),
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
May 2019, The Australasian journal of dermatology,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
February 2012, Journal of hypertension,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
October 2008, Journal of clinical hypertension (Greenwich, Conn.),
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
October 2022, Clinical hypertension,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
June 2009, Journal de pharmacie de Belgique,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
December 2015, European cardiology,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
January 2003, Blood pressure,
James E Sharman, and Faline S Howes, and Geoffrey A Head, and Barry P McGrath, and Michael Stowasser, and Markus Schlaich, and Paul Glasziou, and Mark R Nelson
March 1985, American pharmacy,
Copied contents to your clipboard!